Vascular Events, Vascular Disease and Vascular Risk Factors—Strongly Intertwined with COVID-19
Open Access
- 8 October 2020
- journal article
- review article
- Published by Springer Nature in Current Treatment Options in Neurology
- Vol. 22 (11) , 1-16
Abstract
Purpose of review: To elucidate the intertwining of vascular events, vascular disease and vascular risk factors and COVID-19.Recent findings: Strokes are a leading cause of disability and death worldwide. Vascular risk factors are important drivers of strokes. There are unmodifiable vascular risk factors such as age and ethnicity and modifiable vascular risk factors. According to the INTERSTROKE study, the 10 most frequent modifiable vascular risk factors are arterial hypertension, physical inactivity, overweight, dyslipidaemia, smoking, unhealthy diet, cardiac pathologies, diabetes mellitus, stress/depression and overconsumption of alcohol. Also, infection and inflammation have been shown to increase the risk of stroke. There is high-quality evidence for the clinical benefits of optimal primary and secondary stroke prevention. The COVID-19 pandemic brought a new perspective to this field. Vascular events, vascular disease and vascular risk factors—and COVID-19—are strongly intertwined. An increased risk of vascular events—by multifactorial mechanisms—has been observed in COVID-19 patients. Also, a higher rate of infection with COVID-19, severe COVID-19 and bad outcome has been demonstrated in patients with pre-existing vascular disease and vascular risk factors.Summary: At present, we suggest that regular interactions between healthcare professionals and patients should include education on COVID-19 and on primary and secondary vascular prevention in order to reduce the burden of disease in our ageing populations.Keywords
Funding Information
- University of Bern
This publication has 86 references indexed in Scilit:
- Coronavirus disease (COVID-19): The need to maintain regular physical activity while taking precautionsJournal of Sport and Health Science, 2020
- HighlightsJAMA Neurology, 2020
- Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control studyThe Lancet, 2016
- Endothelial Cell Dysfunction and the Pathobiology of AtherosclerosisCirculation Research, 2016
- Opposing effects of alcohol on the immune systemProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2016
- Evolution of the immune system in humans from infancy to old ageProceedings Of The Royal Society B-Biological Sciences, 2015
- Activation of the GLP-1 Receptor by Liraglutide Increases ACE2 Expression, Reversing Right Ventricle Hypertrophy, and Improving the Production of SP-A and SP-B in the Lungs of Type 1 Diabetes RatsEndocrinology, 2015
- Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: Role of epigenetic histone modificationsBiochemical Pharmacology, 2015
- What’s new in the renin-angiotensin system?Cellular and Molecular Life Sciences, 2004
- Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyThe Lancet, 2004